Labs

Moonshot targets $50B
pre-IPO round as
Kimi K3 fallout
reshapes the race

The Beijing lab is closing a $31.5 billion round and opening a second at up to $50 billion in August, days after Kimi K3 drew White House distillation accusations and a Treasury sanctions warning.

Moonshot AI is closing a private round at a $31.5 billion valuation and, according to people familiar with the matter, plans to open a follow-on in August at up to $50 billion, an 11-fold jump from where the Beijing lab sat at the end of 2025. Bloomberg first reported the pre-IPO structure on July 21; the company is also dismantling its offshore red-chip entity this month in preparation for a Hong Kong Stock Exchange listing within six months, with Goldman Sachs and China International Capital Corp in discussions about bookrunner roles.

The compression of that fundraising calendar isn’t incidental. It’s the direct result of Kimi K3, the open-weight, 2.8-trillion-parameter mixture-of-experts model with a one-million-token context window that Moonshot released on July 17 at the World Artificial Intelligence Conference in Shanghai. Within two days, Moonshot suspended new subscriptions. Daily sales have multiplied at least six times since launch. Annual recurring revenue, which climbed from $200 million in April to $300 million in June, is now the number that private-market investors are indexing against.

K3’s pricing is the strategic tell. The API sits at roughly 60% of Claude Opus 4.8 levels while running two to three times more expensive than domestic peers like Zhipu’s GLM-5.2, a positioning that reads Moonshot out of the Chinese commodity tier and into direct comparison with U.S. frontier labs. “K3 has received positive feedback globally, signaling an all-round catch-up of Chinese LLMs with US leaders in model size, performance, and pricing,” said Morgan Stanley analyst Gary Yu.

The market read the release the same way. Taiwan’s benchmark index fell more than 6%, Japanese equities dropped 4%, and the Nasdaq slid 1.5% in its worst session of the week.

Then Washington moved. On July 22, White House science and technology policy chief Michael Kratsios accused Moonshot of having distilled Anthropic’s Fable, which has only been publicly available since July 1, a timeline that would require the alleged extraction to have occurred inside a 16-day window before K3 shipped. Treasury Secretary Scott Bessent escalated on X: “when PRC firms conduct covert, industrial-scale distillation attacks that cross the line into IP theft, sanctions and Entity List designations will be on the table.” An analyst identified as Sun at Counterpoint has noted the model’s rapid subscription throttling as evidence of genuine demand pressure rather than staged momentum.

What’s on offer to the August round, then, isn’t just a Chinese frontier lab. It’s a bet that a Hong Kong listing, blessed by China’s securities regulator, can close before U.S. sanctions machinery catches up with a model whose training provenance the White House has already publicly questioned. The last comparable regulatory footrace, the 2019 Entity List additions targeting Huawei affiliates, took months to move from accusation to designation. Moonshot’s financial adviser HF Capital, whose confirming WeChat post was quickly deleted, appears to be pricing the same interval.

Sources